Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to evaluate the effect of surgical treatments on the quality of life in hemorrhoidal disease. All available treatment methods will be included in this 1-year cohort which is going to collect data from a big metropol.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hemorrhoidal surgery | Procedure | All surgical interventions under general or local anesthesia, either in the office or operation room, including any type of injection, excision, ligation, ablation, mucopexy and suturation. |
| Measure | Description | Time Frame |
|---|---|---|
| Improvement in Short Health Scale-HD score at 1 year after hemorrhoidal surgery | Changes in quality of life from baseline at 1 year in terms of Short Health Scale (SHS) specific to hemorrhoidal disease (HD) will be reported for each surgical treatment. The SHS-HD scores will be recorded preoperatively, at 1 week, 6 weeks, and 12 months. | 1 year |
| Hemorrhoidal Disease Symptom Score at 1 year after hemorrhoidal surgery | Changes in symptoms from baseline at 1 year will be reported for each surgical treatment. Hemorrhoidal Disease Symptom Score (HDSS) described by Nyström based on 5 cardinal symptoms (pain, itching, bleeding, soiling, and prolapse) will be recorded preoperatively, at 1 week, 6 weeks, and 12 months. | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Recurrence | Determining recurrence rate at 1 year for each treatment. Relapse of patient-reported symptoms (pain, itching, bleeding, soiling, and prolapse) will be recorded at 1 year. | 1 year |
| Complications |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Adults who underwent any interventional treatment other than medical therapy under local and/or general anesthesia will be eligible.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Naciye Cigdem Arslan, MD | Contact | +905313890975 | cigdemarslan@hotmail.it |
| Name | Affiliation | Role |
|---|---|---|
| Naciye Cigdem Arslan, MD | Medipol University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medipol University Bahcelievler Hospital | Recruiting | Istanbul | Bahcelievler | 34196 | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41486915 | Derived | Kement M, Tekin A, Baysal H, Tosun S, Alimoglu O, Sucullu I, Civil O, Sakoglu N, Arslan NC, Tatar C, Nayci AE, Ari A, Cakir E, Kaya R, Turan I, Gulsen T, Meric S, Yavuz E, Bugdayci N, Hamad FM, Leventoglu S, Kozan R, Akpinar O, Yanar H, Yanar F, Kucuk HF, Karahan M, Kaya S, Adiguzel NC, Onder T, Abci I, Aydin AZ, Ozkan OF, Kiziltoprak N, Ozcan B, Orhan A, Canturk AO, Tan M, Bilgin Y, Cok H, Cezit A, Fersahoglu MM, Oncel M. Patient-reported outcomes after hemorrhoid surgery: early results from a prospective, nationwide, real-world, cohort study on diverse approaches. Ann Coloproctol. 2025 Dec;41(6):573-585. doi: 10.3393/ac.2025.00710.0101. Epub 2025 Dec 30. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006484 | Hemorrhoids |
| ID | Term |
|---|---|
| D012002 | Rectal Diseases |
| D007410 | Intestinal Diseases |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Determining early and late complications for each treatment. Early complications (abscess, urinary retention) will be assessed at 6 weeks. Late complications (incontinence, anal stenosis) will be assessed at 12 months.
| 1 year |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |